Funding Opportunities for Bioengineering Technologies for Cancer Diagnosis

The Diagnostic Biomarkers and Technologies Branch (DBTB) of the Cancer Diagnosis Program (CDP) supports the development of technologies that have the potential to be used for analysis of human tumors.

The program funds bioengineering research on:

• Micro-technology, nano-technology or MEMS, lab-on-a-chip, microfabrication, on-chip separation and detection, point-of-care technologies, microfluidics, signal amplification and systems for comprehensive molecular analysis
• Technologies for circulating tumor cells (CTC), dormant cancer cells and other rare cells
• Technologies for automated sample preparation and other automated, high-throughput systems
• Integration of technologies into detection, analysis and/or diagnostic systems
• Technologies for DNA/RNA analysis
• Technologies for proteomic and metabolomic analysis
• Other technologies relevant to cancer diagnosis

The program participates in several funding programs for bioengineering originated from the NIH Bioengineering Consortium (BECON):

The NIH bioengineering program supports basic, applied, and translational bioengineering research that addresses important biological or medical research problems. CDP Contact: Mr. Miguel Ossandon: 240-276-5714, ossandom@mail.nih.gov

Exploratory/Developmental Bioengineering Research Grants [EBRG]: PA-12-284 (R21)

Release/Posted Date: October 14, 2009; Expiration Date: January 8, 2016
Application Receipt Dates: February 16, June 16, October 16

The EBRGs support early bioengineering research. EBRG applications may contain minimal or no preliminary data, and may propose hypothesis-driven, discovery-driven or design-directed research.

Bioengineering Research Grants [BRG]: PAR-13-137 (R01)

Release/Posted Date: October 14, 2009; Expiration Date: May 8, 2016
Application Receipt Dates: February 5, June 5, October 5

The BRGs support multi-disciplinary research performed in in a single laboratory or by multiple organizations. A BRG application may propose hypothesis-driven, discovery-driven, developmental, or design-directed research.

Bioengineering Research Partnerships [BRP]: PAR-10-234 (R01)

Release/Posted Date: July 21, 2010; Expiration Date: January 8, 2014
Application Receipt Dates: February 5, June 5, October 5

The BRPs support large basic, applied, and translational multi-disciplinary research performed by multiple organizations that applies an integrative approach, which includes bioengineering and biomedical/clinical components.

To find out the appropriate funding program for your research please contact:

Miguel Ossandon
ossandom@mail.nih.gov